CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

Propanc Biopharma, Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: 61-03-9882-0780

CIK: 0001517681
EIN: 330662986
State Location: C3
State of Inc.: DE

Nasdaq:PPCB

Form: SCHEDULE 13G/A

Filing Date: 14 Nov 2025
Report Date:
Accepted: 14 Nov 2025 07:05 p.m.
Accession Number: 0001753926-25-001800

Act: 34
File Number: 005-87562
Film Number: 251485880

Documents

Primary Document

Accepted: 14 Nov 2025 07:05 p.m.

0001753926-25-001800-index-headers.html

Last Modified: 14 Nov 2025 02:05 p.m.

0001753926-25-001800-index.html

Last Modified: 14 Nov 2025 02:05 p.m.

0001753926-25-001800.txt

Last Modified: 14 Nov 2025 02:05 p.m.

primary_doc.xml

Last Modified: 14 Nov 2025 02:05 p.m.